Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Workshops, Meetings & Webinars on Food and Dietary Supplements

Workshops, Meetings & Webinars on Food and Dietary Supplements Home
          Food
          News & Events from CFSAN
          Workshops, Meetings & Webinars on Food and Dietary Supplements
          Infant Formula Transition Plan for Exercise of Enforcement Discretion Stakeholder Call - 10/05/2022Workshops, Meetings & Webinars on Food and Dietary Supplements Webcast
    Event Title
              Infant Formula Transition Plan for Exercise of Enforcement Discretion Stakeholder Call


                  October 5, 2022

  

    
  Share
    Post
    Linkedin

    Email
    PrintDate:
          
  



October 5, 2022   

 
 
        
                                      Time: 
                                      
2:00 PM
ET

 





The U.S. Food & Drug Administration (FDA) will host a call for stakeholders on Wednesday, October 5, 2022 at 2 p.m. ET to provide a high-level overview of the Infant Formula Transition Plan for Exercise of Enforcement Discretion and address questions.

The guidance outlines a pathway for manufacturers of infant formula under enforcement discretion to market infant formula products that may not currently comply with specific FDA requirements while they work toward meeting those requirements. Under the new guidance, the period of enforcement discretion for those products identified in the letters of enforcement discretion will be extended until Jan. 6, 2023, with further extensions possible for firms that express interest in and take steps toward the lawful marketing of such products in the United States. The guidance balances the need to ensure that infant formula products meet regulatory requirements with the need for a more resilient infant formula supply.

**Call Link:**Infant Formula Transition Plan for Exercise of Enforcement Discretion Stakeholder Call - YouTube

Agenda

Welcome and Introduction of Speakers/Technical Experts 
	LCDR Janesia Robbs, Communications and Public Engagement Staff, Center for Food Safety and Applied Nutrition (CFSAN), FDA
	Opening Remarks
	Dr. Claudine Kavanaugh, Director, Office of Nutrition and Food Labeling, CFSAN, FDA
	Overview of Infant Formula Transition Plan for Exercise of Enforcement Discretion
	Dr. Patricia A. Hansen, Deputy Director, Office of Nutrition and Food Labeling, CFSAN, FDA
	Question & Answer Session
	LCDR Janesia Robbs, Communications and Public Engagement Staff, CFSAN, FDA
	Dr. Claudine Kavanaugh, Director, Office of Nutrition and Food Labeling, CFSAN, FDA
		Dr. Patricia A. Hansen, Deputy Director, Office of Nutrition and Food Labeling, CFSAN, FDAAdditional Information

Guidance for Industry: Infant Formula Transition Plan for Exercise of Enforcement Discretion
	Press Release: FDA Pathway Supports Long-Term Stability, Diversity of Safe and Nutritious Infant Formula Supply in the U.S.
	Enforcement Discretion to Manufacturers to Increase Infant Formula Supplies
	Resources for Parents and Caregivers on Imported Infant Formula

                                                                                  Content current as of:
      10/03/2022
         
                   
Regulated Product(s)
		 Food & Beverages
			  			     			  						              
			
			
			
			
			
						  Infant Formula & FoodsMore Meetings,
      Conferences, and
      Workshops
        
        Workshops, Meetings & Webinars on Food and Dietary Supplements
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop